Skip to content

Clinical trials

Phase 1/2 Urogenital Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Phase: Phase 1/2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20151
20183
20191
20201
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advanced Accelerator Applications1
Arno Therapeutics1
Blue Earth Therapeutics Ltd1
Janssen Research & Development, LLC1
Lantheus Biosciences Ltd.1
Lipac Oncology LLC1
M.D. Anderson Cancer Center1
Marengo Therapeutics, Inc.1
NanOlogy, LLC1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms13
Prostatic Neoplasms7
Genital Neoplasms, Male6
Neoplasms5
Neoplasms by Site5
Genital Diseases, Male4
Prostatic Diseases4
Urinary Bladder Neoplasms4
Melanoma3
Urologic Neoplasms3

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.